News

UK drug shortages continue to affect pharmacists and patients

2012-02-03 Shortages of brand-name medicines are as much of a problem in 2011 as they were in 2010, according to a survey by the Pharmaceutical Services Negotiating Committee (...
Read more

Members of parliament to hold inquiry into UK drug shortages

2012-01-31 On 21 November 2011, a group of UK members of parliament (MPs) announced that they will hold a full-scale inquiry into the continuing problem of drug shortages withi...
Read more

How originator companies delay generic medicines

2012-01-30 Once a medicine marketed by the originator company is no longer protected by patents or other exclusive rights, generics companies can enter the market with a medici...
Read more

Biosimilars and cancer drug shortages in Europe

2012-01-27 With all the talk about drug shortages in the US it might be easy to forget the rest of the world, but it seems that drug shortages are also hitting European countri...
Read more

EU investigation tackles pay-for-delay

2012-01-26 This is the first of three articles on the EU pharmaceutical sector enquiry.IntroductionIn 2009, the EC reported on an investigation into patent settlements between...
Read more

Generics and biosimilars to drive down drug spending

2012-01-25 A report published by IMS Health on 18 May 2011 predicts a slowing down of the growth in annual spending on medicines, with generics being one of the main contributi...
Read more

Biosimilars use in Europe

2012-01-24 A legal framework for approving biosimilars in the EU was established in 2003 and guidelines for an abbreviated registration process were issued in 2006. However, ac...
Read more

New Amgen Enbrel patent could block biosimilars until 2028

2012-01-23 Amgen announced on 22 November 2011 that it had been granted a new US patent on its blockbuster drug Enbrel (etanercept).The patent No. 8,063,182 describes and claim...
Read more

Actavis launches generic valsartan in Europe

2012-01-20 On 18 November 2011, Iceland-based generics company Actavis announced the launch of generic valsartan and valsartan HCT in nine European countries.The launch of gene...
Read more

The latest on healthcare austerity in Greece

2012-01-19 Greece is seeking to save approximately Euros 900 million a year and reduce the share of gross domestic product accounted for by healthcare spending from more than 1...
Read more

Landmark EU ruling on supplementary protection certificates

2012-01-18 Pharmaceutical industry groups have broadly welcomed a landmark ruling by the Court of Justice of the European Union (CJEU) clarifying the rules on extended patent p...
Read more

Clinical biosimilar data should be accessible to all

2012-01-17 Calls are growing for biosimilar manufacturers to publish their data in the public domain, particular when developing versions of monoclonal antibodies (mAbs) that a...
Read more

Next » 1 2 3 4 5 6 7 ...10

Last update: 2008-09-06 | Go Back | Print View